News & Events
Watchful Waiting Isn’t Right for Everyone
African American men are one population that may be harmed by new guidelines that favor observation over treatment of early stage prostate cancer.
Follow the Doctor's Orders: Jefferson Cardiologists Underscore Long-Term Risks for Patients with Coronary Stents Who Discontinue Medications
In the September issue of the Journal of Invasive Cardiology, Jefferson cardiologists published a warning for physicians and patients alike about an alarming trend they are witnessing first hand – very, very late stent thrombosis.
Next Stop, Jefferson Station!
Beginning September 5, that’s what SEPTA Regional Rail riders will hear as their trains pull into the former Market East Station, when it officially becomes Jefferson Station.
Jefferson Physical Therapy Students Volunteer for Veterans
Volunteers from the Jefferson School of Health Professions were on hand at the National Veterans Wheelchair Games last week to give back to Veterans.
Alexander R. Vaccaro, M.D., Ph.D., Elected President of Rothman Institute & Appointed Chairman of the Department of Orthopaedics at Sidney Kimmel Medical College at Thomas Jefferson University
Alexander R. Vaccaro, M.D., Ph.D., has been elected the new President of Rothman Institute and appointed Chairman of Orthopaedics at Sidney Kimmel Medical College at Thomas Jefferson University.
Wiggly microRNA Binding Implies a More Complex Genome Regulation
Non-standard microRNA silencing interactions appear more prevalent in human biology than previously believed, suggesting more complex roles for microRNAs
Vaccinating Cows Could Answer the Ebola Serum Shortage
Two birds with one stone: A novel and broad Ebola vaccine in humans or with specially engineered cows could help researchers develop large quantities of Anti-Ebola serum and protect humans against filoviruses.
Genomic Analysis of Prostate Cancer Indicates Best Course of Action after Surgery
Does one wait until the cancer comes back or provide men with additional radiation therapy to prevent cancer recurrence? Now, a new study from Thomas Jefferson University shows that a genomic tool can help doctors and patients make a more informed decision.
New Partnership Brings More Personalized Cancer Treatment to Philadelphia
Thomas Jefferson University joins an international genomic medicine collaborative
Congratulations to All of Our Jefferson School of Pharmacy Award Winners for 2014
Congratulations to the winners of our Thomas Jefferson University and Inter-School Awards, TJU Faculty Awards and Student Awards.